Ventures
A young doctor smiles as she talks with an older patient in a hospital

Mar 22, 2018

Start-up Mytonomy partners with Mayo Clinic

Estimated reading time: 1 minute

Share on social media

  • https://www.philips.com.au/healthcare/innovation/philips-ventures/news/mytonomy-partners-with-mayo-clinic Link copied

Contact

Nick Pappas

Nick Pappas

Managing Partner, Venture Investments

Cloud-based patient education platform drives better outcomes

 

Studies show that patient engagement is a key factor in improving outcomes. But many patients don’t have the knowledge they need to take an active role in their care.  The company Mytonomy — applies cognitive learning principles in its cloud-based patient education platform to help fill this information gap. By educating and engaging patients, Mytonomy’s Patient Experience Cloud aims to drive better outcomes and lower costs — and it’s available from any device, anywhere, at any time.

 

In 2017, Philips Health Technology Ventures recognized the potential in Mytonomy and contributed to a $7 million Series-A funding round. Mytonomy’s influence continues to grow, and it recently announced a partnership with the Mayo Clinic to develop a series of short videos for cancer patients and their caregivers. The goal is to encourage shared decision-making between patients and their providers and a better patient and caregiver experience.

Related insights

Want to become a start-up partner with Philips Ventures?

Contact information

* This field is mandatory

*
*
*
*
*

*
*
*
 
Changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.